← Back to Search

CareAvenue for Diabetes

N/A

Waitlist Available

Led By Minal R Patel, PhD, MPH

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 months, 12 months

Awards & highlights

Study Summary

This trial will test an automated e-health tool, CareAvenue, to see if it can help patients with uncontrolled diabetes access resources and improve their self-care.

Eligible Conditions

Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 months, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 months, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in HbA1c as measured by an HbA1c machine

Secondary outcome measures

Change in Cost-Related Non-Adherence Behaviors with prescribed treatment regimens related to diabetes as measured by participant questionnaire

Change in Cost-Related Non-Adherence Behaviors with prescribed treatment regimens related to other conditions being managed as measured by participant questionnaire

Change in Perceived Financial Burden as measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CareAvenueExperimental Treatment1 Intervention

Participants receive access to CareAvenue, an e-health tool, and receive one weekly automated telephone call and 4-5 text messages per week for 52 weeks.

Group II: Guest Assistance ProgramActive Control1 Intervention

Participants receive information about the Guest Assistance Program (GAP) and receive 3-4 text messages per week related to diabetes management and resources for 52 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CareAvenue

2019

N/A

~600

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,797 Previous Clinical Trials

6,377,458 Total Patients Enrolled

10 Trials studying Diabetes

14,885 Patients Enrolled for Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,895 Total Patients Enrolled

106 Trials studying Diabetes

138,063 Patients Enrolled for Diabetes

Minal R Patel, PhD, MPHPrincipal InvestigatorUniversity of Michigan

2 Previous Clinical Trials

374 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals aged 35 and older participate in this experiment?

"This research project is accessible to individuals aged 18 or older, up until the absolute cutoff of 75 years old."

Answered by AI

Under what criteria are individuals eligible to join this clinical experiment?

"This clinical study is seeking 600 participants aged 18-75 who have diabetes. Additionally, these individuals must possess access to a cellular device capable of both sending and receiving text messages as well as not be involved in another concurrent diabetic research venture."

Answered by AI

Are there available slots for those interested in participating in this investigation?

"According to clinicaltrials.gov, this particular investigation is now closed for enrollment and the most recent data was updated on April 20th 2022. Although no longer looking for participants, there are still 1266 other medical trials that need volunteers."

Answered by AI

Recent research and studies

Contemporary Clinical TrialsJournal

Study Protocol: Careavenue Program to Improve Unmet Social Risk Factors and Diabetes Outcomes- A Randomized Controlled Trial

Patel, Minal R., Michele Heisler, John D. Piette, Kenneth Resnicow, Peter X.K. Song, Hae Mi Choe, Xu Shi, Julie Tobi, and Alyssa Smith. 2020. “Study Protocol: Careavenue Program to Improve Unmet Social Risk Factors and Diabetes Outcomes- A Randomized Controlled Trial”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2020.105933.

clinicaltrials.govStudy

Diabetes Outcomes and Unmet Resources

Minal Patel 2019. "Diabetes Outcomes and Unmet Resources". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03950973.